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Abstract
Background: Acute respiratory infections are a leading cause of infectious disease-related morbidity, hospitalisation and
mortality among children worldwide, and particularly in developing countries. In these low-income countries, most patients
with acute respiratory infection (ARI), whether it is mild or severe, are still treated empirically. The aim of the study was to
evaluate the risk factors associated with the evolution and outcome of respiratory illnesses in patients aged under 5 years
old.
Materials and Methods: We conducted a prospective study in a paediatric ward in Antananarivo from November 2010 to
July 2012 including patients under 5 years old suffering from respiratory infections. We collected demographic, socio-
economic, clinical and epidemiological data, and samples for laboratory analysis. Deaths, rapid progression to respiratory
distress during hospitalisation, and hospitalisation for more than 10 days were considered as severe outcomes. We used
multivariate analysis to study the effects of co-infections.
Results: From November 2010 to July 2012, a total of 290 patients were enrolled. Co-infection was found in 192 patients
(70%). Co-infections were more frequent in children under 36 months, with a significant difference for the 19–24 month-old
group (OR: 8.0). Sixty-nine percent (230/290) of the patients recovered fully and without any severe outcome during
hospitalisation; the outcome was scored as severe for 60 children and nine patients (3%) died. Risk factors significantly
associated with worsening evolution during hospitalisation (severe outcome) were admission at age under 6 months
(OR= 5.3), comorbidity (OR= 4.6) and low household income (OR= 4.1).
Conclusion: Co-mordidity, low-income and age under 6 months increase the risk of severe outcome for children infected by
numerous respiratory pathogens. These results highlight the need for implementation of targeted public health policy to
reduce the contribution of respiratory diseases to childhood morbidity and mortality in low income countries.
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Background
Respiratory infections are a major cause of infectious disease-
related morbidity, hospitalisation, and mortality among children
under 5 years old worldwide, and particularly in developing
countries [1].
These diseases are responsible for 4 million deaths worldwide
every year [4]: they are thus among the leading causes of death
and the most common infectious cause of death [2]. Although
many episodes of respiratory infection are mild, 7 to 13 percent
are severe enough to warrant hospitalisation [3]. These diseases
are responsible for at least 6% of the world’s disability and death
[1]. It is estimate that there are 33.7 million cases of respiratory
infection annually among African children and longitudinal studies
suggest that the overall mortality rate among children in
developing countries is between 6.6% and 14.1% [5].
Despite respiratory infections being a public health priority,
data on their epidemiology in Africa are sparse. Diagnostic
methods to identify the pathogen rapidly are not available in low-
incomes settings, so most patient with respiratory infections are
treated empirically with antibiotics based on local epidemiology
[6]. Administering appropriate therapy at the appropriate time
would improve outcomes. These diseases also have an economic
impact, as they lead to substantial consumption of antimicrobial
agents in both community and hospital settings. Furthermore, the
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high frequency of respiratory infections and the excessive use of
antimicrobial agents are major contributors to the development of
antibiotic-resistant pathogens.
Knowing the local epidemiology of respiratory infections is
essential if appropriate empiric therapy is to be prescribed.
Evaluation of mixed infections and the relative importance of each
potential pathogen may also contribute to improving the
understanding of the pathogenesis of these infections [7,8]. Our
study aimed to evaluate the risk factors associated with the
evolution and outcome of respiratory illnesses in patients aged
under 5 years old hospitalised in one of the four main public
hospitals in Antananarivo.
Materials and Methods
Study site
The study was conducted at the ‘‘Centre Hospitalier de
Soavinandriana’’ (CENHOSOA) in Antananarivo, the capital city
of Madagascar, which is located in the central highlands.
Antananarivo consists of administrative, commercial, industrial
and residential areas, with patches of agricultural land, mostly rice
fields. The city is divided into six administrative districts. In
Madagascar, Hib vaccine was introduced in 2008, and Pneumo-
coccia vaccine in 2012
CENHOSOA is a national referral hospital in the third district
of the urban municipality of Antananarivo; hospitalization and
care at this hospital is paid for by the patients. It is located near the
Institut Pasteur of Madagascar (IPM). The paediatric and
neonatology ward of CENHOSOA has 54 beds, and the annual
number of children hospitalized for respiratory infection was
estimated to be 150.
Study design
A prospective, hospital-based, study was conducted at CEN-
HOSOA from November 2010 to July 2012.
The case definition and eligibility criteria used during this study
are described in figure 1.
Demographic, socio-economic, clinical and epidemiological
data were recorded in case report forms (CRFs). Paediatricians
completed the CRFs which were then validated by a clinical
research officer. Instruction sheets were provided to clinical
research officers to ensure accurate data collection. The data
collected was managed by a senior medical epidemiologist.
On admission, trained personnel using standard operating
procedures had collected nasal and throat swabs, and sputum
sample by aspirating airway secretion from the hypopharynx
through the nose or tracheal aspirates. Nasopharyngeal secretions,
tracheal aspirates and sputum were obtained before start of
antibiotic therapy. Specimens were transported within 30 minutes
of sampling to the IPM for tests of respiratory pathogens.
HIV serostatus was not determined; the prevalence of HIV in
Madagascar is low, estimated to be around 1 per 1000 [7].
Ethics statement
The study was approved by the national ethics committee of the
Ministry of Health of Madagascar. Written informed consent was
obtained from parents or legal guardians of children enrolled in
the study. Consenting to be enrolled in the study required consent
to provide samples for diagnosis of influenza and other respiratory
pathogens and to fill out a case report forms (CRFs). Refused
consent and hospitalization within the two weeks before consul-
tation were reasons for exclusion from the study.
Biological analysis
Virological analyses were performed by National Influenza
Centre (NIC).
A panel of multiplex real-time RT-PCR was used for the
detection of viral pathogens in nasopharyngeal swabs. Primers and
probes were obtained from the authors of reported studies or were
developed at the NIC [8]. Viral RNA and DNA were extracted
from 140 ml of each specimen using the QIAamp viral RNA mini
kit and QIAampMinElute virus kit (QIAgen, Courtaboeuf,
France) according to the manufacturer’s protocols. An ABI 7500
Fast real-time PCR system (Applied Biosystems) was used for
amplifications. Each sample was subjected to five different
amplification reactions, each containing primers and probes
specific for two or three viruses such that the following 12
respiratory viruses were targeted as previously described: parain-
fluenza virus 1–3 (PIV), human coronaviruses (hCoV) -OC43, -
229E, -NL63 and HKU1, respiratory syncytial virus (RSV),
human metapneumovirus (hMPV), human rhinovirus (hRV),
adenovirus (AdV) and bocavirus (BoV).
As part of our routine influenza surveillance, screening for
influenza viruses is performed by MDCK cell inoculation and real-
time RT-PCR according to the CDC protocols [9].
Bacteriological analyses were performed by the medical
analysis laboratory of IPM
Gram-stained sputum preparations were examined for polynu-
clear neutrophils (PN) and epithelial cells. The areas of maximal
purulence were examined and graded as follows: class 1: more
than 25 cells and fewer than 10 PN, class 2: more than 25 cells and
10–25 PN, class 3: more than 25 cells and more than 25 PN, class
4: 10–25 cells and more than 25 PN and class 5: fewer than 10
cells and more than 25 PN. Only the classes 4 and 5 present a high
positive predictive value. If the laboratory determined that the
sample was of oral origin it had been rejected. So, classes 1 to 3
had been considered as rejection criteria.
Quantitative sputum cultures were performed on each specimen
by a previously described method [10]: sputum specimens were
homogenized with an equal volume of Digest-EURH on a vortex
mixer; 10 ml aliquots of the homogenate were serially diluted in
saline and 10 ml aliquots of the dilutions were plated with a sterile
inoculator on Blood Columbia agar with nalidixic acid and colistin
(ANC), Chocolate Polyvitex (PVX) agar, and Drigalski agar. Plates
were incubated under 5% CO2 at 35uC for 24 to 48 hours.
Colonies growing on plates inoculated with suitable dilutions were
counted to enumerate each bacterial species present. The
threshold of significance was set at $107/ml (for one or two
species only). Isolates were identified by standard laboratory
methods.
Data analysis
Mono-infection was defined as the presence of only one
pathogen as determined by viral and bacterial analysis. Patients
for which more than one pathogen was detected were considered
to have co-infections.
The outcome was scored as severe if the patient died, or
presented a wrong clinical evolution during hospitalisation
(complication) or the hospitalization was longer than 10 days
(3rd quartile).
Analyses were performed with R software [11]. The nonpara-
metric Wilcoxon test was used to compare means. Qualitative
variables were compared with the Fisher exact test. Statistical
differences were considered significant for p-values,0.05. Multi-
variate backward step-by-step logistic regressions were performed
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to take into account confounders, bias and interactions involving
pathogens linked to the dependent variable. All variables with a p-
value,0.20 were included in the initial model.
Five age groups were defined for the analysis: [0–5] months, [6–
12] months,[13–18] months, [19–24] months, [25–36] months,
.36 months.
Results
From November 2010 to July 2012, 290 children were recruited
from the 301 hospitalized patients eligible. Eleven eligible patients
refused to participate in the study, and they did not differ from
included patients for age, sex or diagnosis on admission.
The baseline demographic and clinical characteristics of the
patients are shown in Table 1. The sex ratio (male/female) was
1.3. The mean of age was 1.1 years [95% CI: 1.0 to 1.2], the age
range was from 1 day to 5 years, and 250 (86%) patients were 2
years old or younger. The diagnoses on admission (Table S1) were
significantly different between the age groups: bronchiolitis was
found more frequently among patients under 6 months old (55%,
p,0.01); LTRI and pneumonia were more frequent among
patients aged over 12 months (respectively, 68% and
85%,p,0.01).
Forty-nine (17%) patients had at least one underlying disease,
with asthma being the most frequent (5%). Some of the children
had underlying conditions, particularly atopy (52; 18%) and
passive exposure to tobacco smoke (113; 39%). Seventy-one (24%)
had been hospitalized during the previous 12 months. Patients
aged under 18 months had significantly more prior hospitalisations
(p = 0.01). The difference between sexes was not statistically
significant.
Around 45% (131/290) of patients had been treated with
antibiotics before hospitalisation (Table S2). Significantly more
patients under than over 12 months old had received antibiotic
treatment before hospitalisation (p,0.01). The difference between
sex was not statistically significant. The frequency of bacterial
detection was lower in the group with prior antibiotic treatment
(49% versus 65%, p = 0.01). No such relationship was found for
viral results.
Accurate information about immunisation was available on
vaccination cards for 82 (26%) children. Eighty-seven percent of
children had completed vaccination against BCG, 77% had
received one Haemophilus influenzae type B vaccination. No child
was vaccinated against Streptococcus pneumoniae and only two were
vaccinated against influenza.
The average of duration of hospitalisation was 7.9 days [95%
CI: 7.1 to 8.6], range 1 to 79 days. The median duration of
hospitalisation was 7 days, and 61% of patients were hospitalised
for more than 7 days. The duration of hospitalisation for living
patients was 8.0 [7.2–8.7] days, and for fatal cases was 3.9 [1.4–
9.2]. There were no significant differences between sex and age
groups.
Discharge information was available for all cases: 79% (230/
290) of patients fully recovered without any complication during
their hospital stay; the condition of 60 children worsened during
hospitalisation, and nine patients (3%) died. All deaths were of
children under 18 months of age, and six (67%) were of children
less than 6 months old.
Figure 1. Eligibility criteria for patients included in the study.
doi:10.1371/journal.pone.0072839.g001
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Mono-infection was found in 81 patients (28%), co-infection was
found in 192 patients (66%). No infectious agents were found in
samples from 17 patients (6%). Overall, 563 pathogens were
isolated during the study period (356 viruses and 207 bacteria)
(table 2).
Table 1. Patient characteristics and main aetiologies according for mono- and co- infections among patients under 5 years old
hospitalised for SARI between November 2010 and July 2012 in Antananarivo, Madagascar.
Total Mono-infection Co-infection p adjusted OR
N=290 (%) N=81 (27.9) N=192 (66.2) [95%CI]
Sex 163 (56.2) 52 (33.5) 103 (66.4) 0.11
Male
Female 127 (43.8) 29 (24.6) 89 (75.4)
Age 111 (38.3) 27(26.7) 74 (73.3) 2.7 [1.0–7.0]
0–5 months
6–12 months 61 (21.0) 24 (40.7) 35 (59.3) 1.5 [0.5–4.1]
13–18 months 34 (11.7) 8 (25.0) 24 (75.0) 0.07 3.4 [1.0–11.2]
19–24 months 24 (8.3) 3(13.0) 20 (87.0) 8.0 [1.7–36.7]
25–36 months 38 (13.1) 9 (25.0) 6 (75.0) 3.1 [0.9–9.9]
.36 months 22 (7.6) 10 (45.5) 12 (54.5) –
Passive smoking 113 (39.0) 33 (31.1) 73 (68.9) 0.68
Number of rooms in the home 34 (11.7) 5 (15.6) 27 (84.4) 0.07
1
.2 256 (88.3) 76 (31.5) 165 (68.5)
Total number of inhabitants in household 198 (68.3) 52 (28.3) 132 (71.7)
,5
6–10 87 (30.0) 28 (33.3) 56 (66.7) 0.67
.10 5 (1.7) 1 (20) 4 (80)
Monthly household income 85 (36.8) 30 (35.3) 55 (64.7) 0.20
,182$
182–455$ 78 (78.8) 18 (23.1) 60 (76.9)
.455$ 68 (29.4) 17 (25.0) 51 (75.0)
Diagnosis on admission 145 (50.0) 38 (27.7) 99 (72.3) 0.51
Bronchiolitis
Lower respiratory tract infection 60 (20.7) 20 (35.1) 37 (64.9) 0.33
Pneumonia 44 (16.1) 13 (29.6) 31 (70.5) 0.99
Respiratory distress 10 (3.5) 2 (22.2) 7 (77.8) 0.97
Comorbidity* 47 (17.2) 10 (21.3) 37 (78.7) 0.22
Atopic** 52 (17.9) 16 (32.0) 34 (68.0) 0.73
Hospitalisation before admission 71 (24.5) 20 (29.0) 49 (71.0) 0.98
Antibiotic prior to hospitalisation 131 (45.2) 43 (35.0) 80 (65.0) 0.09 0.5 [0.3–0.9]
Time to hospitalisation .10 days 50 (17.2) 13 (30.2) 30 (69.8) 0.97
Death 9 (3.1) 1 (12.5) 7 (87.5) 0.44
Pathogens 130 (44.8) 36 (44.4) 94 (49.0) 0.51
Respiratory Syncitial Virus
Influenza A 71 (24.5) 7 (8.6) 64 (33.3) ,0.01 7.9 [3.2–19.3]
Rhinovirus 49 (16.9) 7 (8.6) 42 (21.9) ,0.01 4.4 [1.7–11.2]
Streptococcus pneumoniae 103 (35.5) 7 (8.6) 96 (50.0) ,0.01 11.1 [4.7–26.6]
Haemophilus influenzae de type B 39 (13.5) 1 (1.2) 38 (19.8) ,0.01 20.5 [2.6–161.2]
P value: Fisher’s exact test (univariate analysis), OR adjusted: multivariate analysis (variables with p,0.20 on univariate analysis).
–: reference variable.
*¤Comorbitidy: congenital diseases, malnutrition, prematurity,
**Atopic: including atopic food, drug, acaria pollen or asthma comorbidity.
doi:10.1371/journal.pone.0072839.t001
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RSV was the most frequently detected virus (37%, 130/356),
followed by Influenza type A virus (20%, 71/356) and Rhinovirus
(14%, 49/356) (Table 2).
Streptococcus pneumoniae was most frequently detected bacterial
species (50%, 103/207), followed by Haemophilus influenzae type B
(19%, 39/207) (table 2).
For the patients who died, Streptococcus pneumoniae (56%, 5/9) was
the pathogen most frequently detected, followed RSV (33%, 3/9)
and Influenza type A virus (22% 2/9).
For multivariate analysis of factors possibly associated with co-
infection, sex, age group, number of rooms in the home and
antibiotic treatment before hospitalisation were included in the
initial model.
The multivariate analysis indicated that children under 36
months of age were more often infected by more than one
pathogen; the difference was statistically significant for the 19–24
months old group (adjusted OR = 8.0) (Table 1). Previous
antibiotic treatment before hospitalization was a significantly
protective factor against co-infection (OR = 0.5).
In univariate analysis, Influenza A, Rhinovirus, Streptococcus
pneumoniae, and Haemophilus influenza type B were significantly
associated with co-infections. Haemophilus influenzae and S. pneumo-
Table 2. Aetiological agents and co-infections among patients under 5 years old hospitalised for SARI, November 2010 to July
2012 in Antananarivo, Madagascar.
RSV IA RhV IB AdV hMPV Co BoV PiV Spn Hib
Sta.
aur Brc S
Acin.
bau
Aer.
hydro
Aeroc.
spp
Pseu.
aer
Ent.
spp
List.
sp
Kleb
pn Sta
Ser.
mar
Mora.
sp
Esch.
c
RSV 36 31 12 6 5 2 8 5 1 40 20 3 5 7 1 1 0 0 2 0 3 2 0 1 1
IA - 6 9 9 4 3 2 2 2 28 7 1 3 6 0 0 0 0 0 0 2 1 0 0 0
RhV - - 7 3 6 2 2 4 2 18 7 0 1 2 0 0 0 1 1 0 2 1 0 1 0
IB - - - 2 1 1 1 0 0 5 2 0 0 1 0 0 0 0 0 0 0 1 0 0 0
AdV - - - - 4 0 1 1 0 8 3 0 2 1 0 0 0 0 0 1 0 1 0 0 1
hMPV - - - - - 6 1 0 2 10 3 1 1 1 0 0 0 0 0 0 0 1 0 0 1
Co - - - - - - 2 1 1 7 3 0 1 2 0 0 0 0 1 0 0 0 0 0 0
BoV - - - - - - - 0 0 4 2 1 0 1 0 0 0 0 1 0 0 0 0 0 0
PiV - - - - - - - - 0 4 3 0 1 2 0 1 0 0 0 0 1 0 0 0 0
S.pn - - - - - - - - - 7 25 2 3 2 0 0 0 0 0 0 3 1 0 1 0
Hib - - - - - - - - - - 1 1 0 4 0 0 0 0 0 0 0 1 0 0 0
Sta. aur - - - - - - - - - - - 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Brc - - - - - - - - - - - - 1 1 0 0 0 0 0 0 0 0 1 0 0
S - - - - - - - - - - - - - 5 0 0 0 0 0 0 0 0 0 0 0
Acin bau - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0
Aer. hydro - - - - - - - - - - - - - - - 0 0 0 0 0 0 1 0 0 0
Aeroc. spp - - - - - - - - - - - - - - - - 1 0 0 0 0 0 0 0 0
Pseu aer - - - - - - - - - - - - - - - - - 1 0 0 0 0 0 0 0
Ent. spp - - - - - - - - - - - - - - - - - - 0 0 0 1 0 0 0
List.sp - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0
Kleb pn - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0
Sta - - - - - - - - - - - - - - - - - - - - - 0 0 0 0
Ser.mar - - - - - - - - - - - - - - - - - - - - - - 0 0 0
Mora sp - - - - - - - - - - - - - - - - - - - - - - - 0 0
Esch c - - - - - - - - - - - - - - - - - - - - - - - - 0
Monoinfection 36 6 7 2 4 6 2 0 0 7 1 0 1 5 0 0 1 1 0 0 0 0 0 0 0
2 pathogens 48 34 18 6 10 9 7 3 6 50 10 2 5 4 0 1 0 1 3 1 0 1 1 0 2
3 pathogens 30 17 16 5 4 10 5 4 5 28 17 2 4 7 1 1 0 0 2 0 2 1 0 2 1
4 pathogens 11 12 6 2 3 0 2 1 2 14 7 0 2 3 0 0 0 0 0 0 3 1 0 0 0
5 pathogens 5 2 2 2 2 0 2 2 0 4 4 1 0 1 0 0 0 0 0 0 1 1 0 0 0
Total 130 71 49 17 23 25 18 10 13 103 39 5 12 20 1 2 1 2 5 1 6 4 1 2 3
RSV : Respiratory Syncitial Virus; IA : Influenza A; RhV : Rhinovirus; hMPV : human metapneumovirus;Co : coronavirus_co43/NL63/229E; BoV : Bocavirus; PiV : parainfluenza
virus 1/2/3; Spn : Streptococcus pneumoniae; Hib : Haemophilus influenzae de type b; Sta : Staphylococcus aureus; Brc : Branhamella catharralis; S : Streptococcus mitis/
sanguinis/G/D/equinis/Beta haemolitic; Aero.h : Aero hydromonas; Aeroc spp : Aerococcus spp; Pseu aer : Pseudomonas aeruginosa; List sp : Listeria sp; Ent.spp : Enterobacter
spp; Kleb pn : Klebsiella pneumoniae; Ser Mar : Serritia marcescens; Mora sp : Moraxela species; Esch. c : Escherichia coli.
doi:10.1371/journal.pone.0072839.t002
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niae were most often associated with co-infection (Adjusted
OR = 20.5 and 11.1, respectively) (Table 1).
Univariate analysis showed that a severe outcome was
significantly more frequent for patients with comorbidity
(OR = 3.9), including prematurity or congenital disease (such as
heart disease or cerebral malformation). Also, two of the three
patients presenting with malnutrition died. Hospitalization during
the 12 months prior to admission was also associated with a severe
outcome (OR = 2.1). A low household income, of less than 455
US$ (less than 182 US$ OR = 4.4 and between 182 and 455 US$
OR = 3.5) was associated with severe outcomes.
For multivariate analysis, age group, monthly household
income, admission diagnosis, comorbidities, previous hospitalisa-
tion, and infection with influenza virus type A, RSV and
rhinovirus were included in the initial model.
Multivariate analysis (Table 3) adjusted for these variables
showed that age below 6 months (OR = 5.3), living in a household
with low income (OR = 4.1), and the presence of comorbidities
(OR = 4.6) were significantly aggravating factors. Infection with an
influenza type A virus was a significantly protective factor against a
severe outcome (OR = 0.4 [95% CI = 0.2–0.9]).
Discussion
In the paediatric ward of CENHOSOA, most children under 36
months, hospitalised for respiratory infections, were co-infected,
and the most frequently encountered pathogens were H. influenza,
S. pneumonia, Influenza A and Rhinoviruses. During hospitalisation,
the evolution of respiratory infections was worse for the youngest
children and for those presenting comorbidities and living in low-
income household.
Over all, viral infections made a large contribution to the
burden of infectious respiratory disease. Viral pathogens were
found in 85% of the patients and bacterial pathogens in 57%,
although for 45% of the patients had been treated with antibiotics
before hospitalisation, and this presumably affected the observed
prevalence of bacterial infections.
Our findings for viruses were similar to those of other studies.
For example, the detection rate for viral pathogens was 72% in a
study in Vietnam [12], 50% in a study in Mozambique [13], both
focusing on hospitalised children. These results are consistent with
those for the paediatric ward in CENHOSOA. Our findings are
also consistent with another report from Madagascar indicating
that RSV (30.5%) and by Influenza A (22.6%) are the most
frequent viral causes of community respiratory infection [8].
Few studies in developing countries have addressed the role of
bacterial co-infection in severe respiratory illness. Most focus on
the viral aetiology because molecular diagnosis tools are available
for these pathogens allowing to identify the infection in 80%–95%
of cases [14,15]. In developing countries, laboratory methods to
identify bacterial pathogens are more difficult to implement,
because of the lack of appropriate facilities and material in hospital
laboratories and then, long transit times are prejudicial for stability
of specimens. In our study the transit time was reduced because of
the proximity of the CENHOSOA and the IPM. Unfortunately,
our findings for the rate of bacterial infection may be artificially
low due to prior antibiotic use. In our study, Streptococcus pneumoniae
was the most common bacterial pathogen as in other studies of
hospitalised patients with acute respiratory illness, and Haemophilus
influenzae type B was the next most frequent [16–19].
Primary infection by a respiratory virus increases the risk of
secondary bacterial pneumonia, and viral and bacterial co-
infection is common in young children with pneumonia in
developing countries (about 20–30% of episodes) [20,21].
Evidence of probable mixed viral-bacterial infection has been
recorded in up to 45% of cases of community acquired pneumonia
in children [22–25]. A large proportion of our patients had co-
infection (70%; 192/273) and the [0–6] months age group had the
highest risk. These results are consistent with a study of patients
with community respiratory infection in Madagascar [8]. Viral
and bacterial co-infection was found in 57% of our patients; the
most frequent combination was Streptococcus pneumoniae with one of
several respiratory viruses (88%). Data from Gambia and Nigeria
indicate that mixed bacterial and viral infections may occur in 8 –
40% of cases of childhood pneumonia [26,27]. Recent data from
South Africa indicate that in at least 31% of cases, viral-associated
pneumonia may be due to concurrent infection with Streptococcus
pneumoniae in the absence of vaccination with pneumococcal
conjugate vaccines [28].
Appropriate management of respiratory infections can have a
significant impact on child mortality and it is important to target
priority groups of children most at risk of dying: these groups
include very young infants, children infected with HIV and
malnourished children [29]. In our study, the outcome was severe
for all of the children who presented malnutrition and 67% (2/3)
died. Chisti et al show that the combination of pneumonia with
severe or moderate malnutrition is associated with a high risk of
death: the RR ranges from 2.9 to 121.2 for severe malnutrition,
and from 2.5 to 15.1 for moderate malnutrition. For moderate
malnutrition, RR = 1.2 to 36.5. Several other studies also lead to
the same results [30–33]. Ballard et al. report that malnutrition
and level of parental education both have an impact on the
incidence of respiratory infections [34].
Pneumonia is the leading causes of childhood mortality, and is
responsible for approximately 21% of deaths of African children
under five years of age each year. However, little information is
available about the causes of childhood pneumonia in developing
countries. In our study, only 3% of the patients died; this value is
low. Note that the study population consists of patients from
families with a socioeconomic level that is above the average for
the general population in Madagascar. The patients who died
were more frequently co-infected and under 6 months old. These
results are consistent with other studies on this topic in developing
countries [35,36]. However, study design may have an impact on
the mortality rate observed: indeed all fees for hospitalisation were
paid by the study to allow follow-up to be optimised.
The study identified living in a low-income household as a risk
factor for severe outcome. This is important for patient
management during hospitalisation and also highlights the
consequences of financial barriers to access to vaccination against
influenza and pneumococci. These vaccinations were not included
in the panel of vaccinations in expanded programme of
immunisation (EPI) during this period in Madagascar. They were
only available in private centres and were expensive, and therefore
inaccessible for much of the population. Only two of the patients
included in this study had received vaccination against influenza
and none had received vaccination against pneumococci accord-
ing to their vaccination cards.
Our statistical analysis identified influenza A infection as a
protective factor against a fatal outcome; however, it is well-known
that influenza A may have an impact on high mortality during
major epidemics [37–39].
The co-circulation of influenza A virus, RSV and the high
frequency of Streptococcus pneumoniae in co-infections in children
aged less than 5 years raised issues about the indirect impact of
influenza vaccination on respiratory infections. In particular, the
benefits of establishing a system of vaccination against infectious
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Table 3. Patient characteristics and aetiologies according to outcome among patients under 5 years old hospitalized for SARI,
November 2010 to July 2012, in Antananarivo, Madagascar.
Amelioration Severe outcome crude OR * p- value adjusted OR#
N=230 (%) N=60 (%) [95%CI] [95%CI]
Sex
Male 129 (79.1) 34 (20.9) – 0.99
Female 101 (79.5) 26 (20.5) 0.9 [0.5–1.7]
Age
0–5 months 79 (71.2) 32 (28.8) 1.8 [0.6–5.8] 5.3 [1.3–21.7]
6–12 months 54 (88.5) 7 (11.5) 0.6 [0.2–2.2] 1.4 [0.3–6.6]
13–18 months 27 (79.4) 7 (20.6) 1.2 [0.3–4.6] 0.14 1.8 [0.4–8.0]
19–24 months 20 (83.3) 4 (16.7) 0.9 [0.2–4.1] 1.3 [0.2–7.1]
25–36 months 32 (84.2) 6 (15.8) 0.8 [0.2–3.4] 0.8 [0.2–3.9]
.36 months 18 (81.8) 4 (18.2) – –
Passive smoking 89 (78.8) 24 (21.2) 1.1 [0.6–1.9] 0.88
Number of rooms in the home
1 26 (76.5) 8 (23.5) 1.2 [0.5–2.8]
.2 204 (79.7) 52 (20.3) – 0.66
Monthly household income 64 (71.9) 25 (28.1) 4.4 [1.7–11.5] ,0.01 4.1 [1.5–11.3]
,182$
182–455$ 64 (76.2) 20 (23.8) 3.5 [1.3–9.4] 4.3 [1.5–12.3]
.455$ 68 (91.9) 6 (8.1) – –
Diagnosis on admission
Bronchiolitis 121 (83.5) 24 (16.5) 0.6 [0.3–1.1] 0.11 0.5 [0.2–0.9]
Lower respiratory tract infection 47 (78.3) 13 (21.7) 1.1 [0.5–2.1] 0.86
Pneumonia 34 (72.3) 13 (27.7) 1.6 [0.8–3.3] 0.23
Respiratory distress 6 (60.0) 4 (40.0) 2.7 [0.7–9.8] 0.22
Comorbidity** 28 (57.1) 21 (42.9) 3.9 [2.0–7.5] ,0.01 4.6 [2.1–10.3]
Atopic *** 44 (84.6) 8 (15.4) 0.6 [0.3–1.5] 0.35
Hospitalisation before admission 49 (69.0) 22 (31.0) 2.1 [1.1–3.9] 0.02
Antibiotic prior to hospitalisation 107 (81.7) 24 (18.3) 0.8 [0.4–1.4] 0.39
Biological diagnoses
Viral infections 199 (80.2) 49 (19.8) 0.7 [0.3–1.5] 0.40
Bacterial infections 131 (78.4) 36 (21.6) 1.1 [0.6–2.0] 0.77
Pathogens
Respiratory Syncitial Virus 108 (83.1) 22 (16.9) 0.7 [0.4–1.2] 0.19
Influenza A 62 (87.3) 9 (12.7) 0.5 [0.2–1.0] 0.06 0.4 [0.2–0.9]
Rhinovirus 44 (89.8) 5 (10.2) 0.4 [0.1–1.0] 0.05
Streptococcus pneumoniae 84 (81.5) 19 (18.5) 0.8 [0.4–1.5] 0.55
Haemophilus influenzae de type B 31 (79.5) 8 (20.5) 1.0 [0.4–2.3] 0.97
Coinfection 155 (80.7) 37 (19.3) 1.1 [0.5–2.0] 0.98
Coinfection types
Viral co-infection 40 (93.0) 3 (7.0) 0.2 [0.1–0.9] 0.03
Bacterial co-infection 6 (85.7) 1 (14.3) 0.5 [0.1–4.7] 0.62
Viral and bacterial co-infection 109 (76.8) 33 (23.2) 0.9 [0.5–1.8] 0.97
*Univarite analysis;
#Multivariate analysis (variables with p,0.20 on univariate analysis).
–: reference variable.
**Comorbitidy: congenital diseases, malnutrition, prematurity.
***Atopic: including atopic food, drug, acaria pollen or asthma comorbidity.
doi:10.1371/journal.pone.0072839.t003
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agents for which a vaccine is available should be considered to
provide access to a larger proportion of the population.
In conclusion, we advocate to further research in developing
countries to document in more detail the impact of viral and
bacterial co-infections on the prognosis of severe respiratory
illness. As numerous infections found in our study could be
avoided by immunisation, we recommend that appropriate
vaccination must be rapidly available for all the Malagasy
children. This would reduce mortality among the youngest
children, as this age group currently suffers the greatest burden
of morbidity and mortality associated with respiratory infections.
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